 Riverside Partners, LLC, a Boston-based private equity firm, announced today the completion of an investment in Syner-G Pharma Consulting, LLC ("Syner-G" or the "Company") in partnership with the Company's founders. Syner-G provides the full spectrum of Chemistry, Manufacturing, and Controls ("CMC") technical, regulatory and compliance consulting services to pharmaceutical and biotechnology clients.

Syner-G is a leading provider of customized science and risk-based CMC technical, regulatory and compliance solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. With its high customer retention, Syner-G oversees all aspects of CMC technical, regulatory and compliance services throughout the drug development process and post-commercialization. For more information, visit www.synergpharma.com.  

Riverside Partners Completes Investment in Syner-G

Description

Company Information

Related People

Riverside Partners Completes Investment in Syner-G

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information